* Oscar Health Inc OSCR.N reported quarterly adjusted
earnings
of 62 cents per share for the quarter ended in March, higher
than the same quarter last year, when the company reported EPS
of -18 cents. The mean expectation of five analysts for the
quarter was for earnings of 27 cents per share. Wall Street
expected results to range from 22 cents to 33 cents per share.
* Revenue rose 45.8% to $2.14 billion from a year ago;
analysts
expected $2.01 billion.
* Oscar Health Inc's reported EPS for the quarter was 62
cents.
* The company reported quarterly net income of $177.37
million.
* Oscar Health Inc shares had risen by 27.6% this
quarter and
gained 107.3% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 63.2%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* Wall Street's median 12-month price target for Oscar
Health Inc
is $19.50
This summary was machine generated from LSEG data May 7 at 01:51
p.m. UTC. All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Mar. 31 2024 0.27 0.62 Beat
Dec. 31 2023 -0.72 -0.66 Beat
Sep. 30 2023 -0.47 -0.29 Beat
Jun. 30 2023 -0.23 -0.07 Beat